131 related articles for article (PubMed ID: 9564739)
1. [Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].
Haneda T; Ido A; Fujikane T; Tanaka H; Tanazawa S; Morimoto H; Kato J; Kanaya K; Honda H; Sakai H; Akita N; Hirayama T; Onodera S; Kikuchi K
Nihon Ronen Igakkai Zasshi; 1998 Jan; 35(1):33-8. PubMed ID: 9564739
[TBL] [Abstract][Full Text] [Related]
2. The effects of bisoprolol, a selective beta1-blocker, on glucose metabolism by long-term administration in essential hypertension.
Owada A; Suda S; Hata T; Miyake S
Clin Exp Hypertens; 2001 May; 23(4):305-16. PubMed ID: 11349822
[TBL] [Abstract][Full Text] [Related]
3. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.
Frithz G; Weiner L
Eur J Clin Pharmacol; 1987; 32(1):77-80. PubMed ID: 2884116
[TBL] [Abstract][Full Text] [Related]
4. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
Wang B; Song WH; Liu GZ;
Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):503-5. PubMed ID: 16080839
[TBL] [Abstract][Full Text] [Related]
5. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
[TBL] [Abstract][Full Text] [Related]
6. [Beta blockers for hypertension. No negative influence on insulin resistance].
MMW Fortschr Med; 2002 Feb; 144(8):50. PubMed ID: 11910826
[No Abstract] [Full Text] [Related]
7. Effects of lisinopril and bisoprolol on lipoprotein metabolism in patients with mild-to-moderate essential hypertension.
Saku K; Liu K; Takeda Y; Jimi S; Arakawa K
Clin Ther; 1995; 17(6):1136-46. PubMed ID: 8750405
[TBL] [Abstract][Full Text] [Related]
8. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of bisoprolol and captopril for treatment of essential hypertension in the elderly.
Bracchetti D; Gradnik R; Alberti A; Brunelli A; Orselli L; Leonardi G; Pavesi PC; Cantelli I
Cardiovasc Drugs Ther; 1990 Feb; 4(1):261-4. PubMed ID: 1981017
[TBL] [Abstract][Full Text] [Related]
10. Age dependence of therapy result and risk in the treatment of arterial hypertension?
Höffler D; Morgenstern HO
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
[TBL] [Abstract][Full Text] [Related]
11. Bisoprolol in the treatment of hypertension in the elderly.
Broncel M; Chojnowska-Jezierska J; Adamska-Dyniewska H
J Hum Hypertens; 1998 Sep; 12(9):643-4. PubMed ID: 9783498
[TBL] [Abstract][Full Text] [Related]
12. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Bouvier JM; Rabot D; Herrero G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
[TBL] [Abstract][Full Text] [Related]
14. Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Fogari R; Zoppi A; Corradi L; Preti P; Mugellini A; Lusardi P
J Cardiovasc Pharmacol; 1999 Apr; 33(4):534-9. PubMed ID: 10218722
[TBL] [Abstract][Full Text] [Related]
15. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
Vanmolkot FH; de Hoon JN; van de Ven LL; Van Bortel LM
J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
[TBL] [Abstract][Full Text] [Related]
16. Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension.
Dominguez LJ; Barbagallo M; Jacober SJ; Jacobs DB; Sowers JR
Am J Hypertens; 1997 Dec; 10(12 Pt 1):1349-55. PubMed ID: 9443770
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and tolerance of the bisoprolol/hydrochlorothiazide combination in arterial hypertension].
Luna RL; Oigman W; Ramirez JA; Mion D; Batlouni M; da Rocha JC; Feitosa GS; Castro I; Chaves Júnior Hde C; God EM; Maia LN; Ortega KC; Raineri AM
Arq Bras Cardiol; 1998 Oct; 71(4):601-8. PubMed ID: 10347937
[TBL] [Abstract][Full Text] [Related]
18. Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension.
Paterna S; Parrinello G; Di Pasquale P; Torres D; La Rocca G; Antona R; Vernuccio L; Fornaciari E; Tarantino A; Piccione E; Fasullo S; Licata G
Adv Ther; 2007; 24(6):1260-70. PubMed ID: 18165208
[TBL] [Abstract][Full Text] [Related]
19. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
20. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
Kovacić D; Marinsek M; Gobec L; Lainscak M; Podbregar M
Clin Res Cardiol; 2008 Jan; 97(1):24-31. PubMed ID: 17694376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
